2017-03-17,Threshold Pharmaceuticals And Molecular Templates Agree To Combine
2017-01-26,Research Reports Coverage On Biotech Stocks -- OncoGenex Pharma, INSYS Therapeutics, Threshold Pharma, And AmpliPhi Biosciences
2017-01-13,Hurry! These 5 Stocks Are About to Break Out Explosively
2016-12-19,Threshold Pharmaceuticals And National Cancer Institute To Collaborate On Drug Candidate TH-3424
2016-11-15,Threshold Pharmaceuticals Announces Presentation And Webcast At The Stifel Healthcare Conference 2016
2016-11-07,Threshold Pharmaceuticals Reports Third Quarter Financial Results
2016-10-25,Caris Life Sciences And Threshold Pharmaceuticals Collaborate To Utilize Caris' ADAPT Biotargeting System In The Development Program For Evofosfamide
2016-09-29,Threshold Pharmaceuticals Announces Interim Results From Tarloxotinib Program And Its Plans To Focus On Evofosfamide And Earlier-Stage Opportunities
2016-08-22,One Reason Why Threshold Pharma (THLD) Stock Is Jumping Today
2016-08-18,5 Breakout Stocks Under $10 Set to Soar
2016-08-01,Threshold Pharmaceuticals Reports Second Quarter Financial Results
2016-06-06,Threshold Pharmaceuticals Highlights Multiple Presentations At The 2016 ASCO Annual Meeting
2016-06-01,Threshold Pharmaceuticals To Present At Jefferies 2016 Healthcare Conference
2016-05-10,CytRx Bear Thesis Explained: Why Sarcoma Drug Trial Will Fail
2016-05-05,Threshold Pharmaceuticals Reports First Quarter Financial Results
2016-03-21,Threshold Pharmaceuticals Appoints Stew Kroll As Chief Operating Officer
2016-03-10,Threshold Pharmaceuticals Provides Corporate Update And Reports Fourth Quarter And Year-End 2015 Financial Results
2016-03-01,Threshold Pharmaceuticals Announces Presentation And Webcast At The Cowen And Company 36th Annual Health Care Conference
2015-12-28,Short Interest Moves 50% Lower For THLD
2015-12-08,2 'Rules of the Road' for Biotech Investing
2015-12-04,Why Relypsa Is a New 'Best Idea'
2015-12-03,Threshold Pharmaceuticals (THLD) Weak On High Volume
2015-12-02,Biotech Stock Mailbag: Anavex, Northwest Bio, Threshold Therapeutics
2015-11-24,First Week of THLD January 2016 Options Trading
2015-09-21,Threshold Pharmaceuticals (THLD) Is Weak On High Volume Today
2015-09-12,My Wall Street Fantasy Football League
2015-09-08,Strong On High Volume: Threshold Pharmaceuticals (THLD)
2015-07-21,First Week Of THLD March 2016 Options Trading
2015-05-12,Threshold Pharmaceuticals (THLD) Stock Soars on FDA Fast Track Designation
2015-03-20,Take Aim at Threshold Pharmaceuticals
2015-03-11,Threshold Pharmaceuticals Stock Sees Short Interest Drop 21.8%
2015-01-29,3 Biotech Stocks Under $10 in Breakout Territory: TrovaGene and More
2014-08-22,Biotech Stock Mailbag: Threshold, Galena, CytRx
2014-08-11,5 Stocks Ready for Breakouts
2014-08-01,4 Biotech Stocks Under $10 to Trade for Breakouts
2014-06-11,Interesting THLD Call Options For July 19th
2014-03-27,First Week Of THLD May 17th Options Trading
2014-01-23,First Week Of September 20th Options Trading For Threshold Pharmaceuticals (THLD)
2014-01-17,2 Biotech Stocks Under $10 to Watch
2014-01-13,Top Insider Trades: LOV THLD NHF MBRG
2014-01-06,First Week of February 22nd Options Trading For Threshold Pharmaceuticals (THLD)
2013-10-14,2 Small Cap Biotechs to Bet On
2013-10-09,Interesting THLD Call For November 16th
2013-09-27,Commit To Buy Threshold Pharmaceuticals At $2.50, Earn 8%
2013-08-16,Threshold Pharmaceuticals Enters Oversold Territory (THLD)
2013-07-17,Top Insider Trades: THLD FUND OPK FSFR
2013-05-24,Commit To Buy Threshold Pharmaceuticals At $2.50, Earn 16%
2013-05-15,10 ASCO '13 Abstracts You Can Read Right Now
2013-04-03,SHAREHOLDER ALERT: The Law Firm Of Levi & Korsinsky, LLP Launches An Investigation Into Possible Breaches Of Fiduciary Duty By The Board Of Directors Of Threshold Pharmaceuticals Inc.
2013-03-01,5 Stocks Poised for Breakouts
2013-02-20,4 Biotech Stocks Under $10 Moving Higher
2013-02-12,3 Biotech Stocks Under $10 Moving Higher
2013-01-25,Stocks Continue to Climb as Companies Exceed Expectations
2013-01-25,Biotech Stock Mailbag: Keryx, Sangamo, Threshold and Amarin
2013-01-22,Celgene's Abraxane: Two Month Survival Boost In Pancreatic Cancer Trial
2013-01-08,4 Biotech Stocks Spiking on Unusual Volume
2012-11-27,10 Best-Performing Biopharma Stocks of 2012 and Their 2013 Outlook
2012-11-26,Nate Sadeghi's 2012 Biotech Stock Report Card
2012-11-12,Celgene: Abraxane Boosts Pancreatic Cancer Survival
2012-10-25,Stocks Under $5: Blossoming Biotech Play
2012-10-15,Making The Call: Celgene's Abraxane Will Work in Pancreatic Cancer
2012-10-01,Threshold's Pancreatic Cancer Drug May be Obsolete Before Launch
2012-10-01,Threshold Pharma Seeks to Erase Doubts About Pancreatic Cancer Drug
2012-10-01,Celgene's Abraxane Is Talk of European Cancer Confab
2012-09-25,Celgene CVR: Upside Into Abraxane Pancreatic Cancer Trial Data
2012-09-17,Nasdaq Stocks Posting Largest Percentage Decreases
2012-09-17,Nasdaq Stocks Posting Largest Percentage Decreases
2012-09-17,Threshold's Pancreatic Cancer Drug Boosts Survival -- With an Asterisk
2012-09-14,Biotech Stock Mailbag: Navidea, Celsion, Raptor and Threshold
2012-07-18,Insiders Trading FOLD, THLD, EMMS, MSM
2012-07-16,Cramer's 'Mad Money' Recap: Things Are Better Than You Think
2012-05-30,Threshold Pharmaceuticals Inc. (THLD): Today's Featured Drugs Winner
2012-04-26,Hitting the Ceiling
2012-04-13,5 Stocks Under $10 Poised for Gains
2012-04-05,Biotech Stock Mailbag: Ampio, Cel-Sci and Ziopharm
2012-03-29,3 Stocks Under $10 Moving Higher
2012-03-27,Energy Stocks Look Heavy
2012-03-19,'Mad Money Lightning Round: Freeport-McMoRan Will Surprise
2012-02-27,Clovis Oncology: Like the Story, Not the Stock
2012-02-24,Insiders Trading GHDX, THLD, RVBD
2012-02-23,'Mad Money Lightning Round': Go for American Capital Agency
2012-02-21,Threshold Drug Delays Pancreatic Cancer
2012-02-03,5 Stocks Under $10 Poised for Big Upside
2011-12-23,Biotech Stock Mailbag: Most Important Events for 2012
2011-08-04,Threshold Pharmaceuticals Reports Second Quarter 2011 Financial And Operational Results
2011-07-25,Threshold Pharmaceuticals Announces Initiation Of Clinical Trial Evaluating TH-302 In Combination With Bevacizumab At University Of Texas At San Antonio
2011-07-12,More Hot Biotech Trades for Second Half 2011
2011-07-06,Threshold Pharmaceuticals Announces National Comprehensive Cancer Network (NCCN) Grant For Phase 1 Trial Of TH-302 In Combination With Pazopanib
2011-06-29,Threshold Pharmaceuticals Initiates Clinical Trial Evaluating TH-302 In Combination With Sunitinib
2011-06-22,Threshold Pharmaceuticals To Present At OneMedForum Conference
2011-06-21,Threshold Pharmaceuticals Announces Completion Of Patient Recruitment For Phase 2 TH-302 Pancreatic Cancer Study
2011-03-24,Threshold Pharmaceuticals Reports Fourth Quarter And Year End 2010 Financial Results
2011-03-17,Threshold Pharmaceuticals Completes $30 Million Registered Direct Offering
2011-03-11,Threshold Pharmaceuticals Announces Registered Direct Offering Of $30 Million
2011-02-16,Dean Foods, La-Z Boy: Small-Cap Winners
2011-02-16,Threshold Pharmaceuticals Announces Agreement With The FDA On A Special Protocol Assessment For Planned Phase 3 TH-302 Combination Trial In Advanced Soft Tissue Sarcoma
2011-01-24,Threshold Pharmaceuticals' TH-302 Continues To Demonstrate Promising Activity In Pancreatic Cancer Phase 1/2 Clinical Trial
2010-12-22,Threshold Pharmaceuticals Announces Promising Early Phase 1 Clinical Trial Results In Patients With Advanced Leukemias
2010-11-18,Follow-up Data From Threshold Pharmaceuticals' Phase 1/2 Clinical Trials Of TH-302 Demonstrate Broad Activity In All Combinations Against Multiple Tumor Types
2010-11-12,Threshold Pharmaceuticals Presents Promising Data From A Phase 1/2 Clinical Trial Of TH-302 At International Sarcoma Meeting
2010-11-09,Threshold Pharmaceuticals Announces Additional Medical And Investor Conference Presentations
2010-11-04,Threshold Pharmaceuticals Reports Third Quarter 2010 Financial And Operational Results
2010-11-03,Threshold Pharmaceuticals Awarded $488,958 In Grants Under Qualifying Therapeutic Discovery Project Program
2010-10-12,Threshold Pharmaceuticals Presents Follow-Up Data From A Phase 1/2 Clinical Trial Of TH-302 In Solid Tumors
2010-09-08,Threshold To Present At Rodman & Renshaw Healthcare Conference
2010-08-05,Threshold Pharmaceuticals Reports Second Quarter 2010 Financial And Operational Results
2010-07-13,MBIA, L-1 Identity: Volume Movers
2010-07-12,Threshold Pharmaceuticals Presents Preclinical Results In Two Scientific Presentations At AACR Translational Cancer Medicine Meeting
2010-06-30,Threshold Pharmaceuticals Initiates A Randomized, Controlled, Phase 2 Clinical Trial Evaluating TH-302 In Patients With Advanced Pancreatic Cancer
2010-06-29,Threshold Pharmaceuticals Initiates A Clinical Trial Evaluating TH-302 In Patients With Advanced Leukemias
2010-06-07,Threshold Pharmaceuticals Presents Promising Clinical Trial Results Demonstrating Broad Anti-Tumor Activity
2010-06-03,Threshold Pharmaceuticals Announces A Presentation At The 2010 American Society Of Clinical Oncology (ASCO) Annual Meeting
2010-05-12,Threshold Pharmaceuticals Appoints Dr. David R. Parkinson To Board Of Directors
2010-05-06,Threshold Announces New Vice President Of Corporate Development
2010-01-26,Dynavax, Matrixx: Early Volume Plays
2009-11-06,Threshold Pharmaceuticals 3Q Loss Widens On Costs
2009-10-15,Early Movers: Pump Up the Volume
2009-10-09,Movers Roundup: Callaway Golf, Supervalu
2009-10-09,Threshold Shares Rise On Selected Study Data
2009-10-08,Shareholder Matlinpatterson Sells $31.8M Worth of Huntsman
2007-03-08,Thursday's Early Winners & Losers
2007-03-04,Feuerstein's Biotech Mailbag
2007-02-27,Tuesday's Health Winners & Losers
2007-02-27,Tuesday's Early Winners & Losers
2007-01-30,Tuesday's Early Winners & Losers
2006-12-28,Thursday's Health Winners & Losers
2006-12-28,Thursday's Early Winners & Losers
2006-09-20,Wednesday's Health Winners & Losers
2006-07-17,Monday's Health Winners & Losers
2006-06-02,Friday's Health Winners & Losers
2006-06-02,Friday's Early Winners & Losers
2006-05-19,Take Lessons From Biotech Blowups
2006-05-12,Today's Health Winners and Losers
2006-05-12,Today's Early Winners and Losers
2006-01-05,Medical IPOs Hunt for Cure
2005-11-13,This Week on RealMoney
2005-11-10,On the Threshold of Relief for Older Men
2005-10-12,Health Stocks in Motion
2005-08-19,IPOs for Financial Fashionistas
2005-05-30,Medical IPOs Coming Out Cheap
,
2017-03-17,Threshold Pharmaceuticals And Molecular Templates Agree To Combine
2017-01-26,Research Reports Coverage On Biotech Stocks -- OncoGenex Pharma, INSYS Therapeutics, Threshold Pharma, And AmpliPhi Biosciences
2017-01-13,Hurry! These 5 Stocks Are About to Break Out Explosively
2016-12-19,Threshold Pharmaceuticals And National Cancer Institute To Collaborate On Drug Candidate TH-3424
2016-11-15,Threshold Pharmaceuticals Announces Presentation And Webcast At The Stifel Healthcare Conference 2016
2016-11-07,Threshold Pharmaceuticals Reports Third Quarter Financial Results
2016-10-25,Caris Life Sciences And Threshold Pharmaceuticals Collaborate To Utilize Caris' ADAPT Biotargeting System In The Development Program For Evofosfamide
2016-09-29,Threshold Pharmaceuticals Announces Interim Results From Tarloxotinib Program And Its Plans To Focus On Evofosfamide And Earlier-Stage Opportunities
2016-08-22,One Reason Why Threshold Pharma (THLD) Stock Is Jumping Today
2016-08-18,5 Breakout Stocks Under $10 Set to Soar
2016-08-01,Threshold Pharmaceuticals Reports Second Quarter Financial Results
2016-06-06,Threshold Pharmaceuticals Highlights Multiple Presentations At The 2016 ASCO Annual Meeting
2016-06-01,Threshold Pharmaceuticals To Present At Jefferies 2016 Healthcare Conference
2016-05-10,CytRx Bear Thesis Explained: Why Sarcoma Drug Trial Will Fail
2016-05-05,Threshold Pharmaceuticals Reports First Quarter Financial Results
2016-03-21,Threshold Pharmaceuticals Appoints Stew Kroll As Chief Operating Officer
2016-03-10,Threshold Pharmaceuticals Provides Corporate Update And Reports Fourth Quarter And Year-End 2015 Financial Results
2016-03-01,Threshold Pharmaceuticals Announces Presentation And Webcast At The Cowen And Company 36th Annual Health Care Conference
2015-12-28,Short Interest Moves 50% Lower For THLD
2015-12-08,2 'Rules of the Road' for Biotech Investing
2015-12-04,Why Relypsa Is a New 'Best Idea'
2015-12-03,Threshold Pharmaceuticals (THLD) Weak On High Volume
2015-12-02,Biotech Stock Mailbag: Anavex, Northwest Bio, Threshold Therapeutics
2015-11-24,First Week of THLD January 2016 Options Trading
2015-09-21,Threshold Pharmaceuticals (THLD) Is Weak On High Volume Today
2015-09-12,My Wall Street Fantasy Football League
2015-09-08,Strong On High Volume: Threshold Pharmaceuticals (THLD)
2015-07-21,First Week Of THLD March 2016 Options Trading
2015-05-12,Threshold Pharmaceuticals (THLD) Stock Soars on FDA Fast Track Designation
2015-03-20,Take Aim at Threshold Pharmaceuticals
2015-03-11,Threshold Pharmaceuticals Stock Sees Short Interest Drop 21.8%
2015-01-29,3 Biotech Stocks Under $10 in Breakout Territory: TrovaGene and More
2014-08-22,Biotech Stock Mailbag: Threshold, Galena, CytRx
2014-08-11,5 Stocks Ready for Breakouts
2014-08-01,4 Biotech Stocks Under $10 to Trade for Breakouts
2014-06-11,Interesting THLD Call Options For July 19th
2014-03-27,First Week Of THLD May 17th Options Trading
2014-01-23,First Week Of September 20th Options Trading For Threshold Pharmaceuticals (THLD)
2014-01-17,2 Biotech Stocks Under $10 to Watch
2014-01-13,Top Insider Trades: LOV THLD NHF MBRG
2014-01-06,First Week of February 22nd Options Trading For Threshold Pharmaceuticals (THLD)
2013-10-14,2 Small Cap Biotechs to Bet On
2013-10-09,Interesting THLD Call For November 16th
2013-09-27,Commit To Buy Threshold Pharmaceuticals At $2.50, Earn 8%
2013-08-16,Threshold Pharmaceuticals Enters Oversold Territory (THLD)
2013-07-17,Top Insider Trades: THLD FUND OPK FSFR
2013-05-24,Commit To Buy Threshold Pharmaceuticals At $2.50, Earn 16%
2013-05-15,10 ASCO '13 Abstracts You Can Read Right Now
2013-04-03,SHAREHOLDER ALERT: The Law Firm Of Levi & Korsinsky, LLP Launches An Investigation Into Possible Breaches Of Fiduciary Duty By The Board Of Directors Of Threshold Pharmaceuticals Inc.
2013-03-01,5 Stocks Poised for Breakouts
2013-02-20,4 Biotech Stocks Under $10 Moving Higher
2013-02-12,3 Biotech Stocks Under $10 Moving Higher
2013-01-25,Stocks Continue to Climb as Companies Exceed Expectations
2013-01-25,Biotech Stock Mailbag: Keryx, Sangamo, Threshold and Amarin
2013-01-22,Celgene's Abraxane: Two Month Survival Boost In Pancreatic Cancer Trial
2013-01-08,4 Biotech Stocks Spiking on Unusual Volume
2012-11-27,10 Best-Performing Biopharma Stocks of 2012 and Their 2013 Outlook
2012-11-26,Nate Sadeghi's 2012 Biotech Stock Report Card
2012-11-12,Celgene: Abraxane Boosts Pancreatic Cancer Survival
2012-10-25,Stocks Under $5: Blossoming Biotech Play
2012-10-15,Making The Call: Celgene's Abraxane Will Work in Pancreatic Cancer
2012-10-01,Threshold's Pancreatic Cancer Drug May be Obsolete Before Launch
2012-10-01,Threshold Pharma Seeks to Erase Doubts About Pancreatic Cancer Drug
2012-10-01,Celgene's Abraxane Is Talk of European Cancer Confab
2012-09-25,Celgene CVR: Upside Into Abraxane Pancreatic Cancer Trial Data
2012-09-17,Nasdaq Stocks Posting Largest Percentage Decreases
2012-09-17,Nasdaq Stocks Posting Largest Percentage Decreases
2012-09-17,Threshold's Pancreatic Cancer Drug Boosts Survival -- With an Asterisk
2012-09-14,Biotech Stock Mailbag: Navidea, Celsion, Raptor and Threshold
2012-07-18,Insiders Trading FOLD, THLD, EMMS, MSM
2012-07-16,Cramer's 'Mad Money' Recap: Things Are Better Than You Think
2012-05-30,Threshold Pharmaceuticals Inc. (THLD): Today's Featured Drugs Winner
2012-04-26,Hitting the Ceiling
2012-04-13,5 Stocks Under $10 Poised for Gains
2012-04-05,Biotech Stock Mailbag: Ampio, Cel-Sci and Ziopharm
2012-03-29,3 Stocks Under $10 Moving Higher
2012-03-27,Energy Stocks Look Heavy
2012-03-19,'Mad Money Lightning Round: Freeport-McMoRan Will Surprise
2012-02-27,Clovis Oncology: Like the Story, Not the Stock
2012-02-24,Insiders Trading GHDX, THLD, RVBD
2012-02-23,'Mad Money Lightning Round': Go for American Capital Agency
2012-02-21,Threshold Drug Delays Pancreatic Cancer
2012-02-03,5 Stocks Under $10 Poised for Big Upside
2011-12-23,Biotech Stock Mailbag: Most Important Events for 2012
2011-08-04,Threshold Pharmaceuticals Reports Second Quarter 2011 Financial And Operational Results
2011-07-25,Threshold Pharmaceuticals Announces Initiation Of Clinical Trial Evaluating TH-302 In Combination With Bevacizumab At University Of Texas At San Antonio
2011-07-12,More Hot Biotech Trades for Second Half 2011
2011-07-06,Threshold Pharmaceuticals Announces National Comprehensive Cancer Network (NCCN) Grant For Phase 1 Trial Of TH-302 In Combination With Pazopanib
2011-06-29,Threshold Pharmaceuticals Initiates Clinical Trial Evaluating TH-302 In Combination With Sunitinib
2011-06-22,Threshold Pharmaceuticals To Present At OneMedForum Conference
2011-06-21,Threshold Pharmaceuticals Announces Completion Of Patient Recruitment For Phase 2 TH-302 Pancreatic Cancer Study
2011-03-24,Threshold Pharmaceuticals Reports Fourth Quarter And Year End 2010 Financial Results
2011-03-17,Threshold Pharmaceuticals Completes $30 Million Registered Direct Offering
2011-03-11,Threshold Pharmaceuticals Announces Registered Direct Offering Of $30 Million
2011-02-16,Dean Foods, La-Z Boy: Small-Cap Winners
2011-02-16,Threshold Pharmaceuticals Announces Agreement With The FDA On A Special Protocol Assessment For Planned Phase 3 TH-302 Combination Trial In Advanced Soft Tissue Sarcoma
2011-01-24,Threshold Pharmaceuticals' TH-302 Continues To Demonstrate Promising Activity In Pancreatic Cancer Phase 1/2 Clinical Trial
2010-12-22,Threshold Pharmaceuticals Announces Promising Early Phase 1 Clinical Trial Results In Patients With Advanced Leukemias
2010-11-18,Follow-up Data From Threshold Pharmaceuticals' Phase 1/2 Clinical Trials Of TH-302 Demonstrate Broad Activity In All Combinations Against Multiple Tumor Types
2010-11-12,Threshold Pharmaceuticals Presents Promising Data From A Phase 1/2 Clinical Trial Of TH-302 At International Sarcoma Meeting
2010-11-09,Threshold Pharmaceuticals Announces Additional Medical And Investor Conference Presentations
2010-11-04,Threshold Pharmaceuticals Reports Third Quarter 2010 Financial And Operational Results
2010-11-03,Threshold Pharmaceuticals Awarded $488,958 In Grants Under Qualifying Therapeutic Discovery Project Program
2010-10-12,Threshold Pharmaceuticals Presents Follow-Up Data From A Phase 1/2 Clinical Trial Of TH-302 In Solid Tumors
2010-09-08,Threshold To Present At Rodman & Renshaw Healthcare Conference
2010-08-05,Threshold Pharmaceuticals Reports Second Quarter 2010 Financial And Operational Results
2010-07-13,MBIA, L-1 Identity: Volume Movers
2010-07-12,Threshold Pharmaceuticals Presents Preclinical Results In Two Scientific Presentations At AACR Translational Cancer Medicine Meeting
2010-06-30,Threshold Pharmaceuticals Initiates A Randomized, Controlled, Phase 2 Clinical Trial Evaluating TH-302 In Patients With Advanced Pancreatic Cancer
2010-06-29,Threshold Pharmaceuticals Initiates A Clinical Trial Evaluating TH-302 In Patients With Advanced Leukemias
2010-06-07,Threshold Pharmaceuticals Presents Promising Clinical Trial Results Demonstrating Broad Anti-Tumor Activity
2010-06-03,Threshold Pharmaceuticals Announces A Presentation At The 2010 American Society Of Clinical Oncology (ASCO) Annual Meeting
2010-05-12,Threshold Pharmaceuticals Appoints Dr. David R. Parkinson To Board Of Directors
2010-05-06,Threshold Announces New Vice President Of Corporate Development
2010-01-26,Dynavax, Matrixx: Early Volume Plays
2009-11-06,Threshold Pharmaceuticals 3Q Loss Widens On Costs
2009-10-15,Early Movers: Pump Up the Volume
2009-10-09,Movers Roundup: Callaway Golf, Supervalu
2009-10-09,Threshold Shares Rise On Selected Study Data
2009-10-08,Shareholder Matlinpatterson Sells $31.8M Worth of Huntsman
2007-03-08,Thursday's Early Winners & Losers
2007-03-04,Feuerstein's Biotech Mailbag
2007-02-27,Tuesday's Health Winners & Losers
2007-02-27,Tuesday's Early Winners & Losers
2007-01-30,Tuesday's Early Winners & Losers
2006-12-28,Thursday's Health Winners & Losers
2006-12-28,Thursday's Early Winners & Losers
2006-09-20,Wednesday's Health Winners & Losers
2006-07-17,Monday's Health Winners & Losers
2006-06-02,Friday's Health Winners & Losers
2006-06-02,Friday's Early Winners & Losers
2006-05-19,Take Lessons From Biotech Blowups
2006-05-12,Today's Health Winners and Losers
2006-05-12,Today's Early Winners and Losers
2006-01-05,Medical IPOs Hunt for Cure
2005-11-13,This Week on RealMoney
2005-11-10,On the Threshold of Relief for Older Men
2005-10-12,Health Stocks in Motion
2005-08-19,IPOs for Financial Fashionistas
2005-05-30,Medical IPOs Coming Out Cheap
,
